[ad_1] GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) announced that the US Food and Drug Administration (FDA) has approved, as part of a priority review, kinétra (tafenoquine) single dose for radical …
Read More »Plasmodium vivax treatment, Krintafel, receives the green light from the FDA
